Abstract: A cell thawer is provided. The cell thawer comprises: a thawing part comprising a heating block, which includes a first heating block and a second heating block that form a heating space for heating a container storing a predetermined amount of a biological material including cells, a heater, which is provided in the heating block so that the heating block can be provided with heat, an insulating block, which is coupled to the heating block so as to encompass the heater, and a support, which is for supporting the lower portion of the container in the heating space; a driving part for providing driving force that linearly moves each of the first heating block and the second heating block in the left and right directions; and a control part for controlling the operations of the thawing part and the driving part.

Abstract: A cell thawing device is provided. A cell thawing device according to one embodiment of the present invention is a cell thawing device for thawing biological material comprising cells, the cell thawing device comprising: a housing; a body part which is disposed inside the housing and may form an accommodation space so as to surround at least a portion of a container in which the biological material is stored; a moving part for moving the body part toward the container so that the body part forms the accommodation space; a heating part which is installed in the body part and transfers heat to the container disposed in the accommodation space; and a sensing part for detecting a physical quantity of the body part or the container, wherein a heat transfer space is formed between the body part and the container such that heat can be transferred from the body part to the container in a non-contact manner.

Abstract: A cell thawing machine is provided.

Abstract: A cell thawing machine is provided. The cell thawing machine comprises: a thawing unit that includes heating blocks including a first heating block and a second heating block forming a heating space for heating a container in which a predetermined amount of biological material including cells is stored, heaters installed in the heating blocks to provide heat to the heating blocks, and insulation blocks coupled to the heating blocks so as to surround the heaters; a driving unit that provides driving force for raising and lowering support pins so that the pins can support a lower portion of the container, and moving the first heating block and the second heating block in a straight line to the left and right; and a control unit that controls the thawing unit and the driving unit.

Abstract: Provided are a non-aqueous electrolyte, which includes an organic solvent containing ethylene carbonate, a non-solvent, and a lithium salt, wherein a degree of freedom A of the ethylene carbonate, which is represented by Equation (1), is 30% or less, and a lithium secondary battery including the same-: A={Pfree-EC/(Pfree-EC+PCoordination-EC)}×100??Equation (1): wherein in Equation (1), A is the degree of freedom of the ethylene carbonate, Pfree-EC is an integrated area of a graph which is obtained by deconvolution of a Raman spectrum of the electrolyte with a Gaussian function based on a peak at 893 cm?1, and PCoordination-EC is an integrated area of a graph which is obtained by deconvolution of the Raman spectrum of the electrolyte with a Gaussian function based on a peak at 903 cm?1.

Abstract: The present invention relates to a complex for promoting cartilage differentiation comprising stem cells or a culture thereof and a cartilage cell-free crush, a method for fabricating cartilage by using the complex, cartilage fabricated via the method, a pharmaceutical composition comprising the complex for preventing or treating arthropathy, a method for preventing or treating arthropathy using the composition, a composition for inducing cartilage cell differentiation comprising the prepared cartilage cells, and a method for fabricating cartilage using the prepared cartilage cells.

Abstract: An electrolyte solution additive for a lithium secondary battery, a non-aqueous electrolyte solution for a lithium secondary battery comprising the same, and a lithium secondary battery are described. Specifically, the electrolyte solution additive for a lithium secondary battery may comprise a compound represented by Formula 1, wherein in Formula 1, R1 to R3, L and n are described herein.

Abstract: A lithium secondary battery with improved high-temperature storage characteristics and high-temperature cycle characteristics is described. Such lithium secondary battery includes a positive electrode, a negative electrode including a silicon-based negative electrode active material, a separator disposed between the positive electrode and the negative electrode, and a non-aqueous electrolyte solution containing a lithium salt, an organic solvent, and an additive, wherein the additive may include a compound represented by Formula 1, wherein, in Formula 1, R1 to R3 are described herein.

Abstract: Provided is a method performed by a least one computing device for a message service. The method comprises receiving a transmission request for a compound message which is a bundled message comprising a parent message and a plurality of child messages, obtaining permission information for a sender of the compound message, determining whether to allow each of the child messages to be sent based on the permission information and controlling transmission of the compound message based on the determination result.

Abstract: A non-aqueous electrolyte solution for a lithium secondary battery includes a compound represented by Formula 1 as follows, a lithium salt, and an organic solvent; and a lithium secondary battery including the same: wherein R1 to R3, L1 and A? are described herein.

Abstract: An electrolyte solution additive for a lithium secondary battery, a non-aqueous electrolyte solution for a lithium secondary battery comprising the same, and a lithium secondary battery are described. Specifically, the electrolyte solution additive for a lithium secondary battery may comprise a compound represented by Formula 1, wherein in Formula 1, R1 to R3, L and n are described herein.

Abstract: Provided is a method of calculating volcanic ash dispersion prediction information in real time. The method according to an embodiment of the present disclosure includes collecting volcanic ash advisory texts and weather forecast data in real time, preprocessing the collected volcanic ash advisory texts and weather forecast data, and calculating a volcanic ash eruption rate using some of the preprocessed volcanic ash advisory texts and weather forecast data.

Abstract: Provided is a method for prevention or treatment of a lysosomal storage disorder, and more particularly, to a method that may exhibit excellent efficacy against various lysosomal storage disorders including Niemann-Pick disease by including graphene quantum dots.

Abstract: The present invention may provide a device and a method for detecting and diagnosing sleep apnea, which can accurately determine an apnea state by: extracting a respiration signal of an examinee from a received signal which is a reflection of an impulse signal emitted from at least one IR-UWB radar; setting a threshold value for determining an apnea state from changes in the deviation and interval between peaks of the extracted respiration signal; and comparing the set threshold value with the deviation between the peaks. Therefore, the sleep apnea can be accurately detected and diagnosed using a non-contact/noninvasive method, and thus inconvenience felt by the examinee can be reduced.

Abstract: A non-aqueous electrolyte solution for a lithium secondary battery comprising an organic solvent; a lithium salt; a first additive which is a compound represented by Formula 1; a second additive which is a compound represented by Formula 2; and a third additive which is one or more selected from the group consisting of vinylene carbonate and vinylethylene carbonate, and a lithium secondary battery comprising the non-aqueous electrolyte solution are described: P[OSi(R1)3]3??[Formula 11 wherein R1 and n are described herein.

Abstract: A crampon includes a crampon base for fitting to an underside of an item of footwear, such as a shoe or a boot. A harness extends from the crampon base and may be attached to the crampon base using rivets. The harness and the crampon base define a space for receiving the item of footwear. The crampon base comprises at least one cleat assembly with a cleat base embedded within the crampon base. One or more spikes extend from the cleat base.

Abstract: The present invention pertains to a composition for preventing and treating cancer through mitochondrial metabolism regulation, wherein the composition contains a nanographene structure. It has been confirmed that a specific inhibitory activity on the NIX-dependent pathway among the mitophagy mechanisms in cancer cells inhibits mitochondrial degradation, and thus damaged mitochondria accumulate in the cancer cells, and apoptosis of the cancer cells is induced as a result. Therefore, the composition according to the present invention exhibits excellent anticancer effects that can be applied to various diseases related to the accumulation of abnormal cells, without causing resistance or toxicity, and can thus be effectively used as a cancer prevention or treatment agent or an anticancer treatment adjuvant.

Abstract: The test socket according to the present disclosure is configured to bring terminals of a device under test into contact with electrode pads of a test board, that generates a test signal, to electrically connect the device under test and the tester, the contact part-module configured to allow the contact part to be in an aligned state is separatably coupled to an upper side of the second lower housing of the test socket, so it is possible to easily replace the contact part with new one without separating the test socket from the test board.

Abstract: The present invention relates to a method for treating an immune disease using a calcineurin inhibitor in combination with stem cells. When the pharmaceutical composition comprising a calcineurin inhibitor and mesenchymal stem cells provided by the present invention is used, a significantly higher level of immunosuppressive activity than that obtained using conventional calcineurin inhibitors or mesenchymal stem cells can be obtained. Therefore, it can be used to more effectively prevent or treat immune diseases caused by excessive immunity.

Abstract: The test socket according to the present disclosure is configured to allow terminals of a warped device under test to comes into contact with electrode pads of a tester, which generates a test signal, to perform an electrical test for the device under test, this test socket is configured such that, by the upper plungers, which are separate components from the barrel assembly and have different thicknesses, the terminals of the warped device under test can come simultaneously into contact with the socket pins, thereby applying the same stroke to all the socket pins.